SCHEMBL19742788

SCHEMBL19742788

COc1ccc(CCN(C(=O)O)C(C)(C)C)cc1OCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
BLM P54132 1/20 0.58
APP P05067 1/20 0.55
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MTNR1A P48039 2/20 0.52
MTNR1B P49286 2/20 0.52
SMPD1 P17405 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
BCHE P06276 1/20 0.50
SIGMAR1 Q99720 2/20 0.49
EBP Q15125 1/20 0.49
TMEM97 Q5BJF2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2290451 0.88 CYP3A4 (0.56) KDM4ECYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL3465010 0.81 BCHE (0.62) KDM4ECYP2D6APPMEN1KMT2A
SCHEMBL8728729 0.80 KDM4E (0.72) KDM4ECYP1A2CYP3A4CYP2D6CYP2C9
Oxalic Acid SCHEMBL9077639 0.79 SIGMAR1 (0.71) L3MBTL1SIGMAR1EBPTMEM97
Hydrochloric Acid SCHEMBL8734889 0.79 KDM4E (0.70) KDM4ECYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7822529 0.79 FFAR4 (0.73) KDM4ECYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL12296058 0.77 BCHE (0.61) KDM4ECYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL20482396 0.77 SMPD1 (0.56) KDM4EAPPMEN1KMT2AMTNR1A
SCHEMBL16930277 0.77 SMPD1 (0.56) APPMEN1KMT2AMTNR1AMTNR1B
SCHEMBL21247482 0.76 KMT2A (0.63) MEN1KMT2AL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195189-B2 2-phenethenyltetrahydro isoquinolines useful as anti-HIV compounds Prosetta Antiviral, Inc. (US) 2019-02-05 US disclosed
US-20170368051-A1 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10195189-B2 2-phenethenyltetrahydro isoquinolines useful as anti-HIV compounds MAVS, EIF2AK2, POLRMT KDM4E 289/4885CYP1A2 1713/4885CYP3A4 823/4885
US-20170368051-A1 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS MAVS, EIF2AK2, POLRMT KDM4E 289/4885CYP1A2 1713/4885CYP3A4 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.